HEATHER TRANT: Open Payments
NPI 1336293976 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 35 payments from 8 companies in 2025. Trend: 2023 $20 · 2024 $803 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $207 |
| Janssen Biotech, Inc. | 5 | $197 |
| PFIZER INC. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Ardelyx, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Celltrion USA Inc. | 1 | $29 |
| Madrigal Pharmaceuticals | 1 | $26 |
Products named: TREMFYA, RINVOQ, XELJANZ, ENTYVIO, IBSRELA, XIFAXAN, CREON, VEGZELMA.
Industry payments across LA — which companies pay providers there.
